Overexpression of a kinase-deficient transforming growth factor-β type II receptor in mouse mammary stroma results in increased epithelial branching

Molecular Biology of the Cell

Volumn 10, Issue 4, 1999, Pages 1221-1234

  Joseph, Heather ^a,b   Gorska, Agnieszka E ^b   Sohn, Philip ^b   Moses, Harold L ^b   Serra, Rosa ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; ZINC;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032910954     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.4.1221     Document Type: Article

References (60)

1. Aravamudan, B., Watabe, M., and Watabe, K. (1993). Characterization of the 5′-flanking region of the HGF gene. Biochem. Biophys. Res. Commun. 195, 346-353.
2. Barcellos-Hoff, M.H., Aggeler, J., Ram, T.G., and Bissell, M.J. (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105, 223-235.
3. Bottinger, E.P., Jakubczak, J.L., Roberts, I.S.D., Mumy, M., Hemmati, P., Bagnall, K., Merlino, G., and Wakefield, L.M. (1997). Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16, 2621-2633.
4. Brand, T., MacLellan, W.R., and Schneider, M.D. (1993). A dominant-negative receptor for type β transforming growth factors created by deletion of the kinase domain. J. Biol. Chem. 268, 11500-11503.
5. Brown, P.D., Levy, A.T., Margulies, I.M.K., Liotta, L.A., and Stetler-Steveson, W.G. (1990). Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191.
6. Chen, R.-H., Ebner, R., and Derynck, R. (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260, 1335-1338.
7. Choi, M.E., and Ballermann, B.J. (1995). Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J. Biol. Chem. 270, 21144-21150.
8. Chomerymski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Daniel, C.W., Silberstein, G.B., Van Horn, K., Strickland, P., and Robinson, S. (1989). TGF-β 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev. Biol. 135, 20-30.
10. Defrances, M.C., Wolf, H.K., Michalopoulos, G.K., and Zarnegar, R. (1992). The presence of hepatocyte growth factor in the developing rat. Development 116, 387-395.
11. Ebner, R., Chen, R.-H., Lawler, S., Zioncheck, T., and Derynck, R. (1993). Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science 262, 900-902.
12. Filvaroff, E.H., Ebner, R., and Derynck, R. (1994). Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-β receptor. Development 120, 1085-1095.
13. Gorska, A.E., Joseph, H., Derynck, R., Moses, H.L., and Serra, R. (1998). Dominant-negative interference of the transforming growth factor β type II receptor in mammary epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth & Differ. 9, 229-238.
14. Imagawa, W., Yang, J., Guzman, R., and Satybrata, N. (1994). Control of mammary gland development. In: The Physiology of Reproduction, 2nd ed., ed. E. Knobil and J.D. Neil, New York: Raven Press, 1033-1063.
15. Jhappan, C., Geiser, A.G., Kordon, E.C., Bagheri, D., Hennighausen, L., Roberts, A.B., Smith, G.H., and Merlino, G. (1993). Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12, 1835-1845.
16. Kerr, L.D., Miller, D.B., and Matrisian, L.M. (1990). TGF-β1 inhibition of transin-stromelysin gene expression is mediated through a fos binding sequence. Cell 61, 267-278.
17. Kittrell, F.S., Oborn, C.J., and Medina, D. (1992). Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res. 52, 1924-1932.
18. LeRoith, D., Neuenschwander, S., Wood, T.L., and Hennighausen, L. (1995). Insulin like growth factor I and insulin like growth factor binding protein 3 inhibit involution of the mammary gland following lactation: studies in transgenic mice. Prog. Growth Factor Res. 6, 433-436.
19. Liu, Y., Michalopoulos, G.K., and Zarnegar, R. (1994). Structural and functional characterization of mouse HGF gene promoter. J. Biol. Chem. 269, 4152-4160.
20. Lund, L.R., Riccio, A., Andreasen, P.A., Nielsen, L.S., Kristensen, P., Laiho, M., Saksela, O., Blasi, F., and Dano, K. (1987). Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 6, 1281-1286.
21. Marcotty, C., Frandenne, F., Meuris, S., and Hennen, G. (1994). Immunolocalization and expression of insulin-like growth factor I (IGF-I) in the mammary gland during rat gestation and lactation. Mol. Cell. Endocrinol. 99, 237-243.
22. Matrisian, L.M., Leroy, P., Ruhlmann, C., Gesnel, M.-C., and Breathnach, R. (1986). Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol. Cell. Biol. 6, 1679-1686.
23. Matsumoto, K., Tajima, H., Okazaki, H., and Nakamura, T. (1992). Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J. Biol. Chem. 267, 24917-24920.
24. Montesano, R.K., Matsumoto, T., Nakamura, T., and Orci, L. (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.
25. Moses, H.L., Branum, E.B., Proper, J.A., and Robinson, R.A. (1981). Transforming growth factor production by chemically transformed cells. Cancer Res. 41, 2842-2848.
26. Moses, H.L., and Serra, R. (1996). Regulation of differentiation by TGF-β. Curr. Opin. Genet. Dev. 6, 581-586.
27. Moses, H.L., Yang, E.Y., and Pietenpol, J.A. (1990). TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247.
28. Neuenschwander, S., Schwartz, A., Wood, T.L., Roberts, C.T., and Hennighausen, L. (1996). Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J. Clin. Invest. 97, 2225-2232.
29. Niranjan, B., Buluwela, L., Yant, J., Perusinghe, N., Atherton, A., Phippard, D., Dale, T., Gusterson, B., and Kamalati, T. (1995). HGF/ SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121, 2897-2908.
30. Okajima, A., Miyazawa, K., and Kitamura, N. (1993). Characterization of the promoter region of the rat HGF/SF gene. Eur. J. Biochem. 213, 113-119.
31. Pelton, R.W., Dickinson, M.E., Moses, H.L., and Hogan, B.L.M. (1990). In situ hybridization analysis of TGF-β3 RNA expression during mouse development: comparative studies with TGF-β1 and -β2. Development 110, 600-620.
32. Pierce, D.F., Jr., Gorska, A.E., Chytil, A., Meise, K.S., Page, D.L., Coffey, R.J., Jr., and Moses, H.L. (1995). Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA 92, 4254-4258.
33. Pierce, D.F., Jr., Johnson, M.D., Matsui, Y., Robinson, S.D., Gold, L.I., Purchio, A.F., Daniel, C.W., Hogan, B.L.M., and Moses, H.L. (1993). Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes & Dev. 7, 2308-2317.
34. Richards, D.A., Rodgers, J.R., Supowit, S.C., and Rosen, J.M. (1981). Construction and preliminary characterization of the rat casein and α-lactalbumin cDNA clones. J. Biol. Chem. 256, 526-532.
35. Roberts, A.B., Anzano, M.A., Lamb, L.C., Smith, J.M., and Sporn, M.B. (1981). New class of transforming growth factors potentiated by epidermal growth factor: isolation from nonneoplastic tissues. Proc. Natl. Acad. Sci. USA 78, 5339-5343.
36. Robinson, G.W., and Hennighausen, L. (1997). Inhibin and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124, 2701-2708.
37. Robinson, S.D., Roberts, A.B., and Daniel, C.W. (1993). TGFβ suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy. J. Cell Biol. 120, 245-251.
38. Robinson, S.D., Silberstein, G.B., Roberts, A.B., Flanders, K.C., and Daniel, C.W. (1991). Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development 113, 867-878.
39. Rugh, R. (1968). The Mouse: Its Reproduction and Development, Minneapolis: Burges Publishing.
40. Schulte-Merker, S., Smith, J.C., and Dale, L. (1994). Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction? EMBO J. 13, 3533-3541.
41. Serra, R., Johnson, M., Filvaroff, E.H., LaBorde, J., Sheehan, D.M., Derynck, R., and Moses, H.L. (1997). Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell Biol. 139, 541-552.
42. Silberstein, G.B., and Daniel, C.W. (1987). Reversible inhibition of mammary gland growth by transforming growth factor-β. Science 237, 291-293.
43. Silberstein, G.B., Flanders, K.C., Roberts, A.B., and Daniel, C.W. (1992). Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1. Dev. Biol. 152, 354-362.
44. Silberstein, G.B., Strickland, P., Coleman, S., and Daniel, C.W. (1990). Epithelium-dependent extracellular matrix synthesis in transforming growth factor-β1-growth-inhibited mouse mammary gland. J. Cell Biol. 110, 2209-2219.
45. Soriano, J.V., Pepper, M.S., Nakamura, T., Orci, L., and Montesano, R. (1995). Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108, 413-430.
46. Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R.R. (1992). Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115, 49-58.
47. Streuli, C.H., Bailey, N., and Bissell, M.J. (1991). Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115, 1383-1395.
48. Streuli, C.H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A.P.N., Roskelly, C., and Bissell, M.J. (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129, 591-603.
49. Sudlow, A.W., Wilde, C.J., and Burgoyne, R.D. (1994). Transforming growth factor-β1 inhibits casein secretion from differentiating mammary-gland explants but not from lactating mammary cells. Biochem. J. 304, 333-336.
50. Suzuki, A., Shioda, N., Maeda, T., Tada, M., and Ueno, N. (1994). A mouse TGF-β type I receptor that requires type II receptor for ligand binding. Biochem. Biophys. Res. Commun. 198, 1063-1069.
51. Sympson, C.J., Talhouk, R.S., Alexander, C.M., Chin, J.R., Clift, S.M., Bissell, M.J., and Werb, Z. (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125, 681-692.
52. Takayama, H., LaRochelle, W.J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S.A., and Merlino, G. (1997). Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 94, 701-706.
53. Vassalli, A., Matzuk, M.M., Gardner, H.A., Lee, K.-F., and Jaenisch, R. (1994). Activin/inhibin βB subunit gene disruption leads to defects in eyelid development and female reproduction. Genes & Dev. 8, 414-427.
54. Wang, X.-J., Greenhalgh, D.A., Bickenbach, J.R., Jiang, A., Bundman, D.S., Krieg, T., Derynck, R., and Roop, D.R. (1997). Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc. Natl. Acad. Sci. USA 94, 2386-2391.
55. Westin, G., Gerster, T., Muller, M.M., Schaffner, G., and Schaffner, W. (1987). OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res. 15, 6787-6798.
56. Wieser, R., Attisano, L., Wrana, J.L., and Massagué, J. (1993). Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol. 13, 7239-7247.
57. Witty, J.P., Wright, J.H., and Matrisian, L.M. (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6, 1287-1303.
58. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
59. Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Nieman, C., Hartmann, G., Weidner, K.M., Birchmeier, C., and Birchmeier, W. (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131, 215-226.
60. Zou, H.Y., and Niswander, L. (1996). Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272, 738-741.